272 related articles for article (PubMed ID: 22786681)
1. High-resolution definition of vaccine-elicited B cell responses against the HIV primary receptor binding site.
Sundling C; Li Y; Huynh N; Poulsen C; Wilson R; O'Dell S; Feng Y; Mascola JR; Wyatt RT; Karlsson Hedestam GB
Sci Transl Med; 2012 Jul; 4(142):142ra96. PubMed ID: 22786681
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 gp120-CD4-Induced Antibody Complex Elicits CD4 Binding Site-Specific Antibody Response in Mice.
Galkin A; Chen Y; Guenaga J; O'Dell S; Acevedo R; Steinhardt JJ; Wang Y; Wilson R; Chiang CI; Doria-Rose N; Grishaev AV; Mascola JR; Li Y
J Immunol; 2020 Mar; 204(6):1543-1561. PubMed ID: 32066595
[TBL] [Abstract][Full Text] [Related]
3. Polyfunctional Tier 2-Neutralizing Antibodies Cloned following HIV-1 Env Macaque Immunization Mirror Native Antibodies in a Human Donor.
Spencer DA; Malherbe DC; Vázquez Bernat N; Ádori M; Goldberg B; Dambrauskas N; Henderson H; Pandey S; Cheever T; Barnette P; Sutton WF; Ackerman ME; Kobie JJ; Sather DN; Karlsson Hedestam GB; Haigwood NL; Hessell AJ
J Immunol; 2021 Mar; 206(5):999-1012. PubMed ID: 33472907
[TBL] [Abstract][Full Text] [Related]
4. Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies.
Duan H; Chen X; Boyington JC; Cheng C; Zhang Y; Jafari AJ; Stephens T; Tsybovsky Y; Kalyuzhniy O; Zhao P; Menis S; Nason MC; Normandin E; Mukhamedova M; DeKosky BJ; Wells L; Schief WR; Tian M; Alt FW; Kwong PD; Mascola JR
Immunity; 2018 Aug; 49(2):301-311.e5. PubMed ID: 30076101
[TBL] [Abstract][Full Text] [Related]
5. Near-Pan-neutralizing, Plasma Deconvoluted Antibody N49P6 Mimics Host Receptor CD4 in Its Quaternary Interactions with the HIV-1 Envelope Trimer.
Tolbert WD; Nguyen DN; Tehrani ZR; Sajadi MM; Pazgier M
mBio; 2021 Aug; 12(4):e0127421. PubMed ID: 34281393
[TBL] [Abstract][Full Text] [Related]
6. Structure of an N276-Dependent HIV-1 Neutralizing Antibody Targeting a Rare V5 Glycan Hole Adjacent to the CD4 Binding Site.
Wibmer CK; Gorman J; Anthony CS; Mkhize NN; Druz A; York T; Schmidt SD; Labuschagne P; Louder MK; Bailer RT; Abdool Karim SS; Mascola JR; Williamson C; Moore PL; Kwong PD; Morris L
J Virol; 2016 Nov; 90(22):10220-10235. PubMed ID: 27581986
[TBL] [Abstract][Full Text] [Related]
7. Broadly neutralizing antibody epitopes on HIV-1 particles are exposed after virus interaction with host cells.
Rao PG; Lambert GS; Upadhyay C
J Virol; 2023 Sep; 97(9):e0071023. PubMed ID: 37681958
[TBL] [Abstract][Full Text] [Related]
8. Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure.
Ditzel HJ; Binley JM; Moore JP; Sodroski J; Sullivan N; Sawyer LS; Hendry RM; Yang WP; Barbas CF; Burton DR
J Immunol; 1995 Jan; 154(2):893-906. PubMed ID: 7529290
[TBL] [Abstract][Full Text] [Related]
9. Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1.
Gohain N; Tolbert WD; Acharya P; Yu L; Liu T; Zhao P; Orlandi C; Visciano ML; Kamin-Lewis R; Sajadi MM; Martin L; Robinson JE; Kwong PD; DeVico AL; Ray K; Lewis GK; Pazgier M
J Virol; 2015 Sep; 89(17):8840-54. PubMed ID: 26085162
[TBL] [Abstract][Full Text] [Related]
10. Rational Engraftment of Quaternary-Interactive Acidic Loops for Anti-HIV-1 Antibody Improvement.
Liu Q; Zhang P; Miao H; Lin Y; Kwon YD; Kwong PD; Rikhtegaran-Tehrani Z; Seaman MS; DeVico AL; Sajadi MM; Lusso P
J Virol; 2021 May; 95(12):. PubMed ID: 33827946
[TBL] [Abstract][Full Text] [Related]
11. Vaccine induction of CD4-mimicking HIV-1 broadly neutralizing antibody precursors in macaques.
Saunders KO; Counts J; Thakur B; Stalls V; Edwards R; Manne K; Lu X; Mansouri K; Chen Y; Parks R; Barr M; Sutherland L; Bal J; Havill N; Chen H; Machiele E; Jamieson N; Hora B; Kopp M; Janowska K; Anasti K; Jiang C; Van Itallie E; Venkatayogi S; Eaton A; Henderson R; Barbosa C; Alam SM; Santra S; Weissman D; Moody MA; Cain DW; Tam YK; Lewis M; Williams WB; Wiehe K; Montefiori DC; Acharya P; Haynes BF
Cell; 2024 Jan; 187(1):79-94.e24. PubMed ID: 38181743
[TBL] [Abstract][Full Text] [Related]
12. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing.
Wu X; Zhou T; Zhu J; Zhang B; Georgiev I; Wang C; Chen X; Longo NS; Louder M; McKee K; O'Dell S; Perfetto S; Schmidt SD; Shi W; Wu L; Yang Y; Yang ZY; Yang Z; Zhang Z; Bonsignori M; Crump JA; Kapiga SH; Sam NE; Haynes BF; Simek M; Burton DR; Koff WC; Doria-Rose NA; Connors M; ; Mullikin JC; Nabel GJ; Roederer M; Shapiro L; Kwong PD; Mascola JR
Science; 2011 Sep; 333(6049):1593-602. PubMed ID: 21835983
[TBL] [Abstract][Full Text] [Related]
13. A VRC13-like bNAb response is associated with complex escape pathways in HIV-1 envelope.
Joshi VR; Claiborne DT; Pack ML; Power KA; Newman RM; Batorsky R; Bean DJ; Goroff MS; Lingwood D; Seaman MS; Rosenberg E; Allen TM
J Virol; 2024 Mar; 98(3):e0172023. PubMed ID: 38412036
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 CD4-induced (CD4i) gp120 epitope vaccines promote B and T-cell responses that contribute to reduced viral loads in rhesus macaques.
Thomas MA; Tuero I; Demberg T; Vargas-Inchaustegui DA; Musich T; Xiao P; Venzon D; LaBranche C; Montefiori DC; DiPasquale J; Reed SG; DeVico A; Fouts T; Lewis GK; Gallo RC; Robert-Guroff M
Virology; 2014 Dec; 471-473():81-92. PubMed ID: 25461534
[TBL] [Abstract][Full Text] [Related]
15. Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth.
Roark RS; Li H; Williams WB; Chug H; Mason RD; Gorman J; Wang S; Lee FH; Rando J; Bonsignori M; Hwang KK; Saunders KO; Wiehe K; Moody MA; Hraber PT; Wagh K; Giorgi EE; Russell RM; Bibollet-Ruche F; Liu W; Connell J; Smith AG; DeVoto J; Murphy AI; Smith J; Ding W; Zhao C; Chohan N; Okumura M; Rosario C; Ding Y; Lindemuth E; Bauer AM; Bar KJ; Ambrozak D; Chao CW; Chuang GY; Geng H; Lin BC; Louder MK; Nguyen R; Zhang B; Lewis MG; Raymond DD; Doria-Rose NA; Schramm CA; Douek DC; Roederer M; Kepler TB; Kelsoe G; Mascola JR; Kwong PD; Korber BT; Harrison SC; Haynes BF; Hahn BH; Shaw GM
Science; 2021 Jan; 371(6525):. PubMed ID: 33214287
[TBL] [Abstract][Full Text] [Related]
16. Extensive dissemination and intraclonal maturation of HIV Env vaccine-induced B cell responses.
Phad GE; Pushparaj P; Tran K; Dubrovskaya V; Àdori M; Martinez-Murillo P; Vázquez Bernat N; Singh S; Dionne G; O'Dell S; Bhullar K; Narang S; Sorini C; Villablanca EJ; Sundling C; Murrell B; Mascola JR; Shapiro L; Pancera M; Martin M; Corcoran M; Wyatt RT; Karlsson Hedestam GB
J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31704807
[TBL] [Abstract][Full Text] [Related]
17. An engineered mutant of HIV-1 gp120 formulated with adjuvant Quil A promotes elicitation of antibody responses overlapping the CD4-binding site.
Ahmed FK; Clark BE; Burton DR; Pantophlet R
Vaccine; 2012 Jan; 30(5):922-30. PubMed ID: 22142583
[TBL] [Abstract][Full Text] [Related]
18. Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains.
Wang S; Chan KW; Wei D; Ma X; Liu S; Hu G; Park S; Pan R; Gu Y; Nazzari AF; Olia AS; Xu K; Lin BC; Louder MK; McKee K; Doria-Rose NA; Montefiori D; Seaman MS; Zhou T; Kwong PD; Arthos J; Kong XP; Lu S
Nat Commun; 2024 May; 15(1):4301. PubMed ID: 38773089
[TBL] [Abstract][Full Text] [Related]
19. Generation and Characterization of a Bivalent HIV-1 Subtype C gp120 Protein Boost for Proof-of-Concept HIV Vaccine Efficacy Trials in Southern Africa.
Zambonelli C; Dey AK; Hilt S; Stephenson S; Go EP; Clark DF; Wininger M; Labranche C; Montefiori D; Liao HX; Swanstrom RI; Desaire H; Haynes BF; Carfi A; Barnett SW
PLoS One; 2016; 11(7):e0157391. PubMed ID: 27442017
[TBL] [Abstract][Full Text] [Related]
20. Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM.
Antanasijevic A; Sewall LM; Cottrell CA; Carnathan DG; Jimenez LE; Ngo JT; Silverman JB; Groschel B; Georgeson E; Bhiman J; Bastidas R; LaBranche C; Allen JD; Copps J; Perrett HR; Rantalainen K; Cannac F; Yang YR; de la Peña AT; Rocha RF; Berndsen ZT; Baker D; King NP; Sanders RW; Moore JP; Crotty S; Crispin M; Montefiori DC; Burton DR; Schief WR; Silvestri G; Ward AB
Nat Commun; 2021 Aug; 12(1):4817. PubMed ID: 34376662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
